Skip to main content
Signal8

Tessera Defense & Homeland Security Inc. (HLSQ)

Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dover, DE.

Sector: Services-Prepackaged Software

Industry: Biotechnology

Tessera Defense and Homeland Security Inc logo

Tessera Defense and Homeland Security Inc

OTC:HLSQHealthcare
AH+0.00%$0.0244
Close$0.0244+8.93%
Mkt Cap$634K
EV-$1.58M
Float10.01M
O/S26M
VOL297K sh
$ Vol$7K
RVOL0.22×
Inst Own0.6%
SI0.9%
Net Cash/Sh+$0.11
Dilution
Tessera Defense and Homeland Security Inc logoOTC:HLSQAH$0.0244+0.00%
Financials Summary
Revenue$0
Net Income-$36.2M
Total Assets$5.78M
Free Cash Flow-$26.39M
Debt & Equity
Debt 8%
Preferred 99%
Total Debt$1.44M
Total Equity-$1.3M
Preferred Stock$18.62M
Shares Outstanding
Short Interest

No short interest data available.

Split History3 splits · 3 reverse
2-year cumulative
1:190

Nasdaq bars a compliance period at 1:250

  1. 1:10Reverse split
    Sep 9, 202610 shares → 1
  2. 1:19Reverse split
    Nov 25, 202519 shares → 1
  3. 1:10Reverse split
    Aug 26, 202410 shares → 1
Balance Sheet Details
Assets$5.78M
Liabilities$7.08M
Accounts Receivable$0
Accounts Payable$3.12M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$208K
Income Statement
PeriodFY 2025
CurrencyUSD
Period Ending2025-12-31
Revenue$0
YoY Growth-
Cost of Revenue$0
Gross Profit$0
Gross Margin-
Research and Development$21.29M
Selling, General, and Administrative$8.97M
Other$11.2M
Total Operating Expenses$41.47M
Operating Income (EBIT)-$41.47M
Operating Margin-
Interest Expense$20K
Interest Income$460K
Other Income (Expense)$5.27M
Income Before Tax (EBT)-$36.19M
Income Tax Expense$7K
Net Income-$36.2M
Net Income Margin-
Supplementary Data
EPS-221.90
Diluted EPS-221.90
Weighted Average OS163,103
EBITDA-$33.25M
EBITDA Margin-
Balance Sheet
PeriodFY 2025
CurrencyUSD
Period Ending2025-12-31
Assets
Current Assets
Cash and Cash Equivalents$4.36M
Short-Term Investments$0
Cash and Short-Term Investments$4.36M
Accounts Receivable$0
Inventory$0
Other Current Assets$874K
Total Current Assets$5.58M
Long-Term Assets
Property, Plant & Equipment Net$0
Goodwill$0
Intangible Assets$208K
Long-Term Investments$0
Deferred Tax Assets$0
Other Long-Term Assets$0
Total Long-Term Assets$208K
Other Assets$0
Total Assets$5.78M
Liabilities
Current Liabilities
Accounts Payable$3.12M
Short-Term Debt$0
Current Income Tax Payable$0
Current Unearned Revenue$0
Other Current Liabilities$0
Total Current Liabilities$6.38M
Long-Term Liabilities
Long-Term Debt$0
Long-Term Unearned Revenue$0
Long-Term Deferred Tax Liabilities$0
Other Long-Term Liabilities$706K
Total Long-Term Liabilities$706K
Other Liabilities$0
Total Liabilities$7.08M
Stockholders' Equity
Preferred Stock$18.62M
Common Stock$7K
Retained Earnings-$216.9M
Comprehensive Income & Other$0
Other Stockholders' Equity$215.59M
Total Equity-$1.3M
Minority Interest$0
Total Liabilities and Equity$5.78M
Supplementary Data
Total Debt$1.44M
Net Debt-$2.92M
Cash Flow Statement
PeriodFY 2025
CurrencyUSD
Period Ending2025-12-31
Operating Activities
Net Income-$36.2M
Depreciation & Amortization$2.92M
Deferred Income Tax$0
Stock-Based Compensation$2.09M
Changes in Working Capital:
  Accounts Receivable$0
  Inventory$0
  Accounts Payable$1.24M
  Other Working Capital-$1.26M
Total Working Capital Change-$23K
Other Non-Cash Items$4.82M
Net Cash from Operating-$26.39M
Investing Activities
Capital Expenditures-$2K
Acquisitions$0
Purchases of Investments$0
Sales of Investments$0
Other Investing Activities$110K
Net Cash from Investing$108K
Financing Activities
Debt Repaid-
Common Stock Issuance$13.31M
Common Stock Repurchases$0
Dividends Paid$0
Other Financing Activities-$118K
Net Cash from Financing$13.19M
Forex Effect$73K
Net Change in Cash-$13.02M
Supplementary Data
Operating Cash Flow-$26.39M
Capital Expenditure-$2K
Free Cash Flow-$26.39M
Cash at Beginning$17.98M
Cash at End$4.96M